BioCryst Pharmaceuticals Statistics

Total Valuation

BCRX has a market cap or net worth of $2.53 billion. The enterprise value is $3.15 billion.

Market Cap	2.53B
Enterprise Value	3.15B

Important Dates

The next estimated earnings date is Monday, August 3, 2026, before market open.

Earnings Date	Aug 3, 2026
Ex-Dividend Date	n/a

Share Statistics

BCRX has 254.16 million shares outstanding. The number of shares has increased by 5.23% in one year.

Current Share Class	254.16M
Shares Outstanding	254.16M
Shares Change (YoY)	+5.23%
Shares Change (QoQ)	+10.49%
Owned by Insiders (%)	0.89%
Owned by Institutions (%)	86.58%
Float	221.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	36.76
PS Ratio	2.85
Forward PS	3.65
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	8.14
P/OCF Ratio	8.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 10.14.

EV / Earnings	n/a
EV / Sales	3.55
EV / EBITDA	9.64
EV / EBIT	9.76
EV / FCF	10.14

Financial Position

The company has a current ratio of 1.91

Current Ratio	1.91
Quick Ratio	1.78
Debt / Equity	n/a
Debt / EBITDA	2.61
Debt / FCF	2.76
Interest Coverage	4.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	42.62%
Return on Invested Capital (ROIC)	431.76%
Return on Capital Employed (ROCE)	119.50%
Weighted Average Cost of Capital (WACC)	7.25%
Revenue Per Employee	$2.04M
Profits Per Employee	-$1.05M
Employee Count	435
Asset Turnover	1.87
Inventory Turnover	32.20

Taxes

In the past 12 months, BCRX has paid $3.81 million in taxes.

Income Tax	3.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.05% in the last 52 weeks. The beta is 0.57, so BCRX's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+2.05%
50-Day Moving Average	8.92
200-Day Moving Average	7.97
Relative Strength Index (RSI)	68.12
Average Volume (20 Days)	5,542,749

Short Selling Information

The latest short interest is 40.64 million, so 15.99% of the outstanding shares have been sold short.

Short Interest	40.64M
Short Previous Month	36.65M
Short % of Shares Out	15.99%
Short % of Float	18.39%
Short Ratio (days to cover)	10.68

Income Statement

In the last 12 months, BCRX had revenue of $885.72 million and -$457.98 million in losses. Loss per share was -$2.10.

Revenue	885.72M
Gross Profit	678.70M
Operating Income	322.24M
Pretax Income	-454.18M
Net Income	-457.98M
EBITDA	326.46M
EBIT	322.24M
Loss Per Share	-$2.10

Full Income Statement

Balance Sheet

The company has $238.40 million in cash and $858.08 million in debt, giving a net cash position of -$619.68 million or -$2.44 per share.

Cash & Cash Equivalents	238.40M
Total Debt	858.08M
Net Cash	-619.68M
Net Cash Per Share	-$2.44
Equity (Book Value)	-553.84M
Book Value Per Share	-2.18
Working Capital	178.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $313.10 million and capital expenditures -$2.73 million, giving a free cash flow of $310.37 million.

Operating Cash Flow	313.10M
Capital Expenditures	-2.73M
Depreciation & Amortization	4.22M
Net Borrowing	64.94M
Free Cash Flow	310.37M
FCF Per Share	$1.22

Full Cash Flow Statement

Margins

Gross margin is 76.63%, with operating and profit margins of 36.38% and -51.71%.

Gross Margin	76.63%
Operating Margin	36.38%
Pretax Margin	-51.28%
Profit Margin	-51.71%
EBITDA Margin	36.86%
EBIT Margin	36.38%
FCF Margin	35.04%

Dividends & Yields

BCRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.23%
Shareholder Yield	-5.23%
Earnings Yield	-18.13%
FCF Yield	12.29%

Analyst Forecast

The average price target for BCRX is $21.30, which is 114.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.30
Price Target Difference	114.29%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (3Y)	0.56%
EPS Growth Forecast (3Y)	24.00%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BCRX has an Altman Z-Score of -1.01 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.01
Piotroski F-Score	5